LYN anticorps (N-Term)

N° du produit ABIN928741

Cet anticorps Lapin Polyclonal détecte spécifiquement LYN dans WB. Il présente une réactivité envers Humain et Souris.

Aperçu rapide pour LYN anticorps (N-Term) (ABIN928741)

Antigène: LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LYN est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-LYN anticorps

Épitope: N-Term

Réactivité croisée: Souris

Purification: Purified

Immunogène: Lyn antibody was raised in rabbit using the N terminal of Lyn as the immunogen

Information d'application

Indications d'application: Optimal conditions should be determined by the investigator.

Commentaires:

Lyn Blocking Peptide, (ABIN5614610), is also available for use as a blocking control in assays to test for specificity of this Lyn antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur LYN

Antigène: LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))

Autre désignation: Lyn

Sujet: Lyn down regulates expression of stem cell growth factor receptor (KIT). Acts as an effector of EpoR (erythropoietin receptor) in controlling KIT expression and may play a central role in erythroid differentiation during the switch between proliferation and maturation. Synonyms: Polyclonal Lyn antibody, Anti-Lyn antibody, Yamaguchi sarcoma viral, v-yes-1 oncogene homolog antibody, AA407514 antibody, Hck-2 antibody.

Pathways: Fc-epsilon Receptor Signaling Pathway, Hormone Transport, Response to Growth Hormone Stimulus, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling, Integrin Complex, BCR Signaling